Literature DB >> 7650535

Dysfunction of visual pathways in HIV-1 infection.

R Malessa1, M W Agelink, H C Diener.   

Abstract

Foveal and conventional full field pattern-shift visual evoked potentials (f-VEPs and c-VEPs) were recorded bilaterally in 100 HIV seropositive homosexual men (HIVs) and in 40 age-matched healthy controls. In HIVs, both f-VEPs and c-VEPs revealed a significant mean increase in P100 latency (p < 0.001). In stage WR2 early conduction changes were detected in 17% of the stimulated eyes by f-VEPs and in 3% by c-VEPs. In patients with CD4 cell counts below 100/microliters a 33% reduction in the mean c-VEP amplitude was found (ANOVA p < 0.01). Multivariate analyses (MANCOVA) revealed that CD4 cell depletion was independently associated with lower (p < 0.01) and zidovudine treatment with higher c-VEP amplitudes (p < 0.05). Also patients with severe CD4 cell depletion showed a trend towards higher c-VEP amplitudes (p = 0.09) and lower f-VEP latencies (p = 0.08) after long lasting zidovudine treatment (Kruskal-Wallis test). Our data suggest that f-VEPs are a sensitive measure of subclinical optic fiber dysfunction in early HIV-1 infection and that axonal loss of optic fibers emerges with manifest immune deficiency. The inverse correlation of VEP changes and zidovudine treatment merits further studies on the question, whether inhibition of HIV replication may preserve visual pathway function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650535     DOI: 10.1016/0022-510x(95)00002-j

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Latent ocular deviations in patients with advanced AIDS.

Authors:  E España-Gregori; R Montés-Micó; I Bueno-Gimeno; M Díaz-Llopi; J L Menezo-Rozalén
Journal:  Doc Ophthalmol       Date:  2001-11       Impact factor: 2.379

2.  Neuro-ophthalmological disorders in HIV infected subjects with neurological manifestations.

Authors:  J-C Mwanza; L K Nyamabo; T Tylleskär; G T Plant
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

3.  Pattern- and motion-related visual evoked potentials in HIV-infected adults.

Authors:  Jana Szanyi; Jan Kremlacek; Zuzana Kubova; Miroslav Kuba; Pavel Gebousky; Jaroslav Kapla; Juraj Szanyi; Frantisek Vit; Jana Langrova
Journal:  Doc Ophthalmol       Date:  2017-01-10       Impact factor: 2.379

4.  Visual evoked and event-related brain potentials in HIV-infected adults: a longitudinal study over 2.5 years.

Authors:  Jana Szanyi; Jan Kremlacek; Zuzana Kubova; Miroslav Kuba; Pavel Gebousky; Jaroslav Kapla; Juraj Szanyi; Frantisek Vit; Jana Langrova
Journal:  Doc Ophthalmol       Date:  2019-04-16       Impact factor: 2.379

5.  Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentials.

Authors:  Mariam Riazi; Joanne K Marcario; Frank K Samson; Himanshu Kenjale; Istvan Adany; Vincent Staggs; Emily Ledford; Janet Marquis; Opendra Narayan; Paul D Cheney
Journal:  J Neuroimmune Pharmacol       Date:  2009-03-13       Impact factor: 4.147

Review 6.  Behavioral and neurophysiological hallmarks of simian immunodeficiency virus infection in macaque monkeys.

Authors:  P D Cheney; M Riazi; J M Marcario
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

7.  Early clinical and subclinical visual evoked potential and Humphrey's visual field defects in cryptococcal meningitis.

Authors:  Anand Moodley; William Rae; Ahmed Bhigjee; Cathy Connolly; Natasha Devparsad; Andrew Michowicz; Thomas Harrison; Angela Loyse
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.